CVI Investments, Inc. 13D and 13G filings for Galmed Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:51 pm Unchanged | 2025-09-30 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 173,333 3.100% | 0 (Unchanged) | Filing |
| 2025-08-14 2:01 pm Purchase | 2025-06-30 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 173,333 7.100% | 6,075 (+3.63%) | Filing |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 167,258 9.900% | 167,258 (New Position) | Filing |